Halozyme Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.1M | 59k | 52.36 |
| 2024-03-31 | $16M | 395k | 40.68 |
| 2023-12-31 | $3.6M | 96k | 36.96 |
| 2023-09-30 | $8.2M | 214k | 38.20 |
| 2023-06-30 | $9.7M | 269k | 36.07 |
| 2023-03-31 | $11M | 276k | 38.19 |
| 2022-12-31 | $3.5M | 62k | 56.90 |
| 2022-09-30 | $4.7M | 119k | 39.54 |
| 2021-12-31 | $284k | 7.1k | 40.17 |
| 2021-09-30 | $6.4M | 157k | 40.68 |
| 2021-06-30 | $12M | 265k | 45.41 |
| 2020-12-31 | $1.4M | 32k | 42.70 |
| 2018-03-31 | $784k | 40k | 19.60 |
| 2016-03-31 | $128k | 14k | 9.48 |
| 2014-12-31 | $7.3M | 759k | 9.65 |